Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2023)

Dianthus Therapeutics (DNTH) posted quarterly Treasury Shares of $63.0 for Q3 2023, down 99.61% quarter-over-quarter from $16084.0 in Q4 2022.

Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2023) Analysis & Trends

Dianthus Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $63.0 for Q3 2023.

In Q3 2023, Treasury Shares changed N/A year-over-year to $63.0; the TTM figure through Sep 2023 stood at $63.0 (changed N/A YoY), while the FY2022 annual figure was $33.3 million, up 11398.52% from the prior year.
Treasury Shares for Q3 2023 stood at $63.0, down from $16084.0 in the prior quarter.
The five-year high for Treasury Shares was $289918.0 in Q4 2021, with the low at $63.0 in Q3 2023.
The 5-year median for Treasury Shares is $205000.0 (2020), against an average of $143357.4.
The sharpest annual moves came in 2021 and 2022: Treasury Shares soared 41.42% in 2021, then slumped 94.45% in 2022.
Dianthus Therapeutics' Treasury Shares stood at $205722.0 in 2019, then retreated by 0.35% to $205000.0 in 2020, then surged by 41.42% to $289918.0 in 2021, then plunged by 94.45% to $16084.0 in 2022, then sank by 99.61% to $63.0 in 2023.
Business Quant data shows DNTH's Treasury Shares at $63.0 in Q3 2023, $16084.0 in Q4 2022, and $289918.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Dianthus Therapeutics	4.97 Bn	4.57 Bn	-	-

Download Data